We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content

Economic Aspects of Cancer Screening

  • Chapter
Evaluation of Cancer Screening

Part of the book series: Focus on Cancer ((3292))

  • 62 Accesses

Abstract

Recognition that resources are limited has led to a growing concern for efficiency in the provision of health care in the UK, which has been heightened with the advent of the recent NHS reforms. Purchasing agencies, such as fundholding general practitioners, and providers, such as hospital trusts, are now expected to take on the more traditional economic roles of consumers and producers, responding to market mechanisms and improving, in the process, the efficiency of health care delivery [48]. Clinton’s health reform plan for the US takes a parallel position, whereby it is proposed that large groups of American employers act as purchasing agencies who will negotiate with insurers. They, in turn, will negotiate with doctors to find high quality care at the lowest cost [42]. It should not be surprising, therefore, to learn that the demand for economic skills has grown alongside these changes. One of the most important sets of skills that economists can offer in this context is that of economic appraisal techniques. These help decision makers (both purchasers and providers) to address three particular questions: which health care programmes are worthwhile undertaking, whether alternative configurations of the programmes, other than the existing ones, result in better value for money and how such programmes should be organised so that scarce resources are not needlessly wasted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bethwaite J, Rayner T, Bethwaite P (1986) Economic aspects of screening for cervical cancer in New Zealand. NZ Med J 99:747–751.

    CAS  Google Scholar 

  2. Bourne TH, Campbell S, Reynolds KM et al. (1993) Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br Med J 306:1025–1029.

    Article  CAS  Google Scholar 

  3. Brown J, Sculpher M (1993) Economics of screening programmes to prevent cervical cancer. Contemp Rev Obstet Gynaecol 5:221–229.

    Google Scholar 

  4. Buxton M, Ashby J, O’Hanlon M (1987) Alternative methods of valuing health states. HERG Discussion Paper No. 2. Health Economics Research Group, Brunei University.

    Google Scholar 

  5. Cairns J (1992) Discounting and health benefits: another perspective. Health Econ 1:76–79.

    Article  PubMed  CAS  Google Scholar 

  6. Cairns J, Shackley P (1993) Sometimes sensitive, seldom specific: a review of the economics of screening. Health Econ 2:43–53.

    Article  PubMed  CAS  Google Scholar 

  7. Campion MJ, Brown JR, McCance DJ et al. (1988) Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 95:175–181.

    Article  PubMed  CAS  Google Scholar 

  8. Chadwick DJ, Kemple T, Astley JP et al. (1991) Pilot study of screening for prostate cancer in general practice. Lancet 338:613–616.

    Article  PubMed  CAS  Google Scholar 

  9. Chamberlain J (1990) Is screening for colorectal cancer worthwhile? Br J Cancer 62:1–3.

    Article  PubMed  CAS  Google Scholar 

  10. Chodak GW, Schoenberg HW (1984) Early detection of prostate cancer by routine screening. JAMA 252:3261–3264.

    Article  PubMed  CAS  Google Scholar 

  11. Coppleson LW, Brown B (1976) The prevention of carcinoma of the cervix. Am J Obstet Gynecol 125:153–159.

    PubMed  CAS  Google Scholar 

  12. Cristofolini M, Bianchi R, Boi S et al. (1993) Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer 71:370–374.

    Article  PubMed  CAS  Google Scholar 

  13. de Haes JCJM, de Koning HJ, van Oortmarssen GJ, van Agt HME, de Bruyn AE, van der Maas PJ (1991) The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 49:538–544.

    Article  PubMed  Google Scholar 

  14. de Koning HJ, van Ineveld BM, van Oortmarssen GJ et al. (1991) Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49:531–537.

    Article  PubMed  Google Scholar 

  15. Drummond MF (1989) Principles of economical appraisal in health care. Oxford University Press, Oxford.

    Google Scholar 

  16. Drummond MF, Stoddard GL, Torrance GW (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford

    Google Scholar 

  17. Drummond MF, Torrance G, Mason J (1993) Cost-effectiveness league tables: More harm than good? Soc Sci Med 37:33–40.

    Article  PubMed  CAS  Google Scholar 

  18. Eddy DM (1990) Screening for cervical cancer. Ann Internal Med 113:214–226.

    CAS  Google Scholar 

  19. Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P (1989) Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 60:781–784.

    Article  PubMed  CAS  Google Scholar 

  20. Feaver GP (1990) Screening for oral cancer and precancer. Dent Pract May, 16–18.

    Google Scholar 

  21. Forrest P (1988) Breast Cancer Screening. Report to the Health Minister of England, Wales, Scotland and Northern Ireland. Department of Health and Social Security, HMSO, London.

    Google Scholar 

  22. Fraser MN, Clarke PR (1992) Cost-effectiveness of breast cancer screening. The Breast 1:169–172.

    Article  Google Scholar 

  23. Gerard K, Mooney G (1993) QALY league tables: handle with care. Health Econ 2:59–64.

    Article  PubMed  CAS  Google Scholar 

  24. Gram IT, Lund E, Slenker SE (1990) Quality of life following a false positive mammogram. Br J Cancer 62:1018–1022.

    Article  PubMed  CAS  Google Scholar 

  25. Gram IT, Slenker SE (1992) Cancer anxiety and attitudes towards mammography among screening attenders, nonattenders and women never invited. Am J Public Health 82:249–251.

    Article  PubMed  CAS  Google Scholar 

  26. Grimes DS (1988) Value of a negative cervical smear. Br Med J 296:1363.

    Article  CAS  Google Scholar 

  27. Hall J (1992) A cost-utility analysis of mammography screening in Australia. Soc Sci Med 34:993–1004.

    Article  PubMed  CAS  Google Scholar 

  28. Hardcastle JD, Chamberlain J, Sheffield J et al. (1989) Randomised controlled trial of faecal occult blood screening for colorectal cancer. Results of the first 107 349 subjects. Lancet i:1160–1164.

    Google Scholar 

  29. Jacobs I, Prys Davies A, Bridges J et al. (1993) Prevalence screening for ovarian cancer in post menopausal women by CA 125 measurement and ultrasonography. Br Med J 306:1030–1034.

    Article  CAS  Google Scholar 

  30. Knox EG (1976) Ages and frequencies for cervical cancer screening. Br J Cancer 34:444–452.

    Article  PubMed  CAS  Google Scholar 

  31. Koopmanschap MA, Lubbe KTN, van Oortmarssen GJ, van Agt HMA, van Ballegooijen M, Habbema JDF (1990) Economic aspects of cervical cancer screening. Soc Sci Med 30:1081–1987.

    Article  PubMed  CAS  Google Scholar 

  32. Loomes G, McKenzie L (1989) The use of QALYs in health care decision making. Soc Sci Med 28:299–308.

    Article  PubMed  CAS  Google Scholar 

  33. Love RR, Fryback DG, Kimbrough SR (1985) A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination. Med Decis Making 5(3):263–178.

    Article  PubMed  CAS  Google Scholar 

  34. MacLean U, Sinfield D, Klein S, Harden B (1984) Women who decline breast screening. J Epidemiol Community Health 38:278–283.

    Article  PubMed  CAS  Google Scholar 

  35. Marteau TM, Walker P, Giles J, Smail M (1990) Anxieties in women undergoing colpos-copy. Br J Obstet Gynaecol 97:859–861.

    Article  PubMed  CAS  Google Scholar 

  36. Mason J, Drummond M, Torrance G (1993) Some guidelines of the use of cost effectiveness league tables. Br Med J 306:570–572.

    Article  CAS  Google Scholar 

  37. Mooney G, Olsen JA (1991) QALYs: Where next? In: McGuire A, Fenn P, Mayhew K (eds) Providing health care. Oxford University Press, Oxford, pp 120–140.

    Google Scholar 

  38. Nally F (1988) Oral cancer (letter). Br Dent J 165:240.

    Article  PubMed  CAS  Google Scholar 

  39. Nord E (1992) Methods for quality adjustment of life years. Soc Sci Med 34(5):559–569.

    Article  Google Scholar 

  40. Parsonage M, Neuburger H (1992) Discounting health benefits. Health Econ 1:71–76.

    Article  PubMed  CAS  Google Scholar 

  41. Pedersen KV, Carlsson P, Varenhorst E, Lofman O, Berglund K (1990) Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. Br Med J 300:1041–1044.

    Article  CAS  Google Scholar 

  42. Roberts JC (1993) How Clinton’s reforms compare with the NHS. Br Med J 307:820.

    Google Scholar 

  43. Robinson R (1993) Cost and cost-minimisation analysis. Br Med J 307:726–728.

    Article  CAS  Google Scholar 

  44. Rosser R, Kind P (1978) A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol 7:347–358.

    Article  PubMed  CAS  Google Scholar 

  45. Sackett DL, Torrence GW (1978) The utility of different health states as perceived by the general public. J Chron Dis 31:697–704.

    Article  PubMed  CAS  Google Scholar 

  46. Schneider J, Twiggs LB (1972) The cost of carcinoma of the cervix. Obstet Gynecol 40:851–858.

    PubMed  CAS  Google Scholar 

  47. Schroder FH (1993) Prostate cancer: to screen or not to screen? Br Med J 306:407–408.

    Article  CAS  Google Scholar 

  48. Secretaries of State for Health, Wales, Northern Ireland and Scotland (1989) Working for patients: the health service: caring for the 1990s. HMSO, London.

    Google Scholar 

  49. Simpson P, Chamberlain J, Gravelle HSE (1978) Choice of screening tests. J Epidemiol Community Health 32:166–170.

    Article  PubMed  CAS  Google Scholar 

  50. Smith A, Chamberlain J (1987) Managing cervical screening. In: Information technology in health care, Issue 4. Kluwer Publishing Ltd, Kingston upon Thames, pp 2–12.

    Google Scholar 

  51. Torrance GW (1986) Measurement of health-state utilities for economic appraisal: A review. J Health Econ 5:1–30.

    Article  PubMed  CAS  Google Scholar 

  52. van Ballegooijen M, Habbema JDF, van Oortmarssen GJ, Koopmanschap MA, Lubbe JTN, van Agt HME (1992) Preventive pap-smears: balancing costs, risks and benefits. Br J Cancer 65:930–933.

    Article  PubMed  Google Scholar 

  53. van Ballegooijen M, Koopmanschap MA, Tjokrowardojo AJS, van Oortmarssen GJ (1992) Care and costs for advanced cervical cancer. Eur J Cancer 28A:1703–1708.

    Article  PubMed  Google Scholar 

  54. Walker A, Whynes DK, Thomas WM, Chamberlain JO, Hardcastle JD (1991) Retesting positive results in screening for colorectal cancer: a marginal analysis. Appl Econ 23:1015–1017.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag London Limited

About this chapter

Cite this chapter

Brown, J. (1996). Economic Aspects of Cancer Screening. In: Chamberlain, J., Moss, S. (eds) Evaluation of Cancer Screening. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-3044-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3044-4_10

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19957-1

  • Online ISBN: 978-1-4471-3044-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics